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A previous investigation of the arsenical type of superficial
epithelioma made by one of us (1) (H. M.) revealed the pertinent
clinical, histopathologic, histochemical and chemical features of
this entity. In the report of this study emphasis was given to the
fact that the epithelioma provoked by ingestion of arsenic differs
from the lesions of superficial epitheliomatosis (2) and Bowen's
disease (3), and that by proper evaluation of various findings the
distinction usually can be made in each case.
In the interim since this report was published studies along the
same lines have been continued. We shall report briefly the
accumulated results of further observations, which in general con-
firm the conclusions in the earlier paper. At this point it should
be stated that the nature of the action of arsenic is obscure and
that little has been written in recent years on the role of arsenic
as a carcinogenic agent. We are in accord with the suggestion
of Cook and his colleagues (4) that arsenic is deserving of more
attention by workers engaged in cancer research.
MATERIAL AND FINDINGS
Our additional material includes six cases of superficial epi-
thelioma induced by arsenic in which biopsies of skin were ob-
tained; two cases in which arsenical epitheliomas were associated
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with lesions of superficial epitheliomatosis, and fourteen cases of
superficial epitheliomatosis. Most of these lesions were studied
both by the methods of quantitative chemical analysis (5) and
histochemical examination (6).
Specimens for biopsy were obtained in cases of superficial epi-
theliomatosis so that a control group of observations might be
available for comparison with those made in the cases of arsenical
epithelioma. As would be expected, most of the lesions of super-
ficial epitheliomatosis were of the basal cell type, a form which,
as has been emphasized in a previous report, rarely occurs in
response to the action of arsenic. In only one instance could
arsenic be demonstrated in the tumor. It is, therefore, evident
that arsenic occurs exceptionally in lesions of superficial epithelio-
matosis. However, the presence of arsenic in the tissue does not
predicate the diagnosis of arsenical epithelioma in the absence
of other essential factors.
In the cases of arsenical epithelioma, our findings were similar
to those recorded previously: arsenic was present in every lesion
examined and could be demonstrated by either chemical or histo-
logic technic. In every case, Osborne's method gave positive
results, and comparison with adjoining normal skin showed a
greater concentration of arsenic in the epithelioma. It happens,
however, that this histochemical finding was not always cor-
roborated by the quantitative chemical procedure, probably be-
cause the specimens of tissue in some instances were so small and
the amount of the arsenic reported therein so tiny.
CLINICAL AND HISTOPATHOLOGIC ASPECTS
The following cases are cited to illustrate certain of the features
encountered in the study of these lesions:
Case 1. A man, aged forty-nine years, who registered at the Mayo Clinic on
January 20, 1938, had had psoriasis since the age of seventeen years. In 1912
Fowler's solution (solution of potassium arsenite, LJ.S.P.) had been administered
for treatment of the psoriasis, and until 1932 a course of the medication was
repeated at least once yearly, always with beneficial effects on the psoriasis. In
1927 keratoses first appeared on the palms and soles. Fifteen months before the
patient came to the clinic, a verrucous lesion on one thenar eminence became
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ulcerated, and subsequently others of the keratoses enlarged and broke down.
These were treated by his physician in his home locality.
Examination at the clinic disclosed two elevated, firm, tender keratotic nodules
on the left palm, many palmar keratoses, a papillomatous lesion on the right
temple, with pearly telangiectatic border, and numerous firm infiltrated crusted
plaques with pearly telangiectatic borders over the trunk and upper extremities.
A subcutaneous plaque about 2 cm. in diameter was present over the right cheek,
just lateral to the bridge of the nose, and corresponding to it, a tumor protruded
into the anterior portion of the right nasal fossa. Extensive patches of psoriasis
covered the trunk, extremities, and also the face and scalp; the nails were altered
typically. The patient volunteered the information that the lesions of the palms
and soles and the crusted lesions of the trunk differed in appearance from those of
psoriasis. There was no question of origin of new growth on a pre-existing psori-
atic plaque.
The tumors (as well as the keratoses) were excised or destroyed by fulguration
and electrocautery. Those on the trunk disclosed the histologic structure of
squamous cell epithelioma, grade 2, of the arsenical type; some also contained a
few areas of basal cell epithelioma. The plaque on the right cheek proved to be of
basal cell origin, and that in the right nasal fossa was reported by the surgical
pathologist as a "very inflammatory degenerating carcinoma, probably of basal
cell type."
By chemical analysis of the excised epitheliomas, the presence of arsenic was
demonstrated in each specimen; the quantity varied from 0.00024 to 4.3 mgm. per
gram of tissue. Examination of normal skin revealed 0.00008 mgm. of arsenic
per gram of tissue. Arsenic was not detected in the urine.
In July, 1938, a pearly nodule was excised by the patient's physician from the
scar on the left thenar eminence. This proved microscopically to be squamous
cell epithelioma, grade 2. With the Osborne method crystals of arsenic trisulfide
were demonstrable in the epidermis; these were concentrated much more abund-
dantly in the area occupied by epithelioma than in the adjacent normal epidermis.
Arsenic as indicated in case 1 may appear in varying concentra-
tions in different lesions on the same person. That arsenic is
deposited erratically in the epithelial structures is indicated by
the following observations: 1) analyses of skin, hair and nails may
fail to disclose arsenic despite known ingestion of the agent;
2) hair and also urine of the patient often do not yield any evi-
dence of arsenic on analysis even when the epithelioma and adjoin-
ing normal skin give positive results, and 3) occasionally the hair
may contain appreciable amounts of arsenic when skin and nails
have none. The factors which account for the distribution of
arsenic in the tissues and in the cutaneous appendages are not
yet known.
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Ca8e 2. A woman, aged sixty-nine years, who registered at the Mayo Clinic on
February 6, 1935, had numerous keratotic and crusted nodules on the trunk and
extremities, in places distinctly grouped. The duration of this condition was
given as two years. Removal of crusts resulted in bleeding. A verrucous lesion
had been present on the left fifth finger for five years; roentgen therapy was ad-
ministered at one time without healing the lesion. Plaques with a fine threadlike
border were not observed.
Doses of a solution of potassium arsenite had been taken for nine months in
1915, for five weeks in 1932 and for one week in December, 1934. The general
examination of the patient did not reveal any significant abnormalities aside from
those on the skin.
Excision and examination of lesions on the trunk and arms revealed them to be
squamous cell epitheliomas, grade 1 and 2, with intracellular vacuolation in ad-
dition to distinct Bowen-like features. Crystals of arsenic trisulfide were found
in all sections stained by Osborne's method. Two lesions on the trunk, one,
squamous cell epithelioma, grade 1 and the other, grade 2 when subjected to
chemical analysis, yielded respectively 0.275 and 0.022 mgm. of arsenic per gram of
tissue. From a fragment of unaffected skin, weighing 10 mgm., it was calculated
that the skin contained 1 mgm. of arsenic in each gram. It is probable, however,
that a technical error accounted for this high figure. The specimen was small
for estimation of its arsenic content to be reliable. With Osborne's stain only a
few crystals were observed in the section.
The left fifth finger was amputated. Microscopically the lesion was shown to
be squamous cell epithelioma, grade 1. One examination of the complete output
of urine for twenty-four hours for arsenic gave negative results.
Two aspects are deserving of mention in this case: 1) the dis-
parity, already alluded to, between the quantitative arsenic con-
tent of the tumors and of normal skin, and 2) the absence of
arsenical keratoses on the palms or soles, and of other features of
arsenic intoxication such as pigmentation and hepatitis. Focal
concentrations of arsenic may occur in the skin without develop-
ment of epithelioma. We have found, by chemical examination,
that arsenic is occasionally present in appreciable quantities in
the skin in a variety of noncarcinomatous diseases of the skin.
It is hardly likely that the mere presence of arsenic in these cases
need signify the possibility of future epitheliomatous change.
With regard to the second point, it may be remarked that many
of the lesions were clinically and histologically analogous to kerato-
ses (figs. 1 and 2a).
Case 3 illustrates that a history of ingestion of, or exposure to,
arsenic is not always obtainable, even in the presence of unim-
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peachable evidence of arsenical sequelae, and also that arsenical
epitheliomas on the trunk may be limited to a few solitary lesions.
Case 3•* A dentist, sixty-seven years of age, was seen in the Department of
Dermatology of the Research and Educational Hospitals of the University of
Illinois on March 15, 1934, for treatment of two crusted superficial epitheliomas on
Fin. 1 (case 2). Group of arsenical epitheliomas on arm simulating arsenical
keratoses of palms or soles, both clinically and pathologically (see figure 2a)
and large lesion on abdomen simulating Bowen's disease. Note absence of thread-
like pearly border.
the back. The lesions, described as arciform in configuration, had been present
for two or three years. Keratoses on the palms and soles apparently were not
noted. Treatment consisted of applications of solid carbon dioxide and ad-
ditional destruction with the actual cautery.
The patient was seen again on February 25, 1941, because of a crusted ulcer
on the left index finger; this had appeared four years previously. Numerous
arsenical keratoses were present on the palms, and a few were observed on the
soles. The two circular, superficial epitheliomas had recurred at the site of
* This case is reported with permission of Dr. Francis E. Senear, head of the
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Fm. 2a. Keratosis on arm, same lesion as shown in figure 1; histologically
squamous cell epithelioma, grade 2, with malignant dyskeratosis, vacuolation
of epithelial cells and giant cells and early invasion of cutis; b, arsenical kera-
tosis squamous cell cpithelioma, grade 1 in situ, simulating the histologic pic-
ture of Bowen's disease with malignant dyskeratosis, giant epithelial cells and
epithclial giant cells.
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previous treatment on the back. Careful questioning did not elicit any informa-
tion with regard to ingestion of arsenic at any time in the past.
The lesions on the back were excised, and the one on the finger was removed
with the cautery. Microscopic sections showed in each site squamous cell
epithelioma, grade 1, with Bowen-like features. Quantitative analysis of the
tissue for arsenic was performed in the laboratory of the coroner of Cook County
through the courtesy of Dr. Clarence W. Muehlberger, coroner's toxicologist,
with the following results: (1) epitheliomas from the back contained 0.0026 mgm.
of arsenic per gram of tissue; (2) epithelioma from the finger, 0.020 mgm. of
arsenic per gram of tissue; and (3) normal skin, 0.0019 mgm. of arsenic per gram
of tissue. Osborne's stains demonstrated crystals of arsenic trisulfide within
the epitheliomas.
The appearance of palmar and plantar keratoses induced by
arsenic is sufficiently familiar to make its description unnecessary.
The early microscopic changes in the malignant alteration of
arsenical keratosis consist of keratinization and vacuolation of
individual cells in the epidermis (malignant dyskeratosis, fig. 2b).
Clinically this is manifested by growth and ulceration of the
keratosis. Further development results in features of penetra-
tion and invasion, when the continuity of the basal cell layer is
destroyed, so that squamous cell epithelioma, grade 2 or 3, is
recognized. We have not seen basal cell epithelioma arising from
arsenical keratosis but possibly such an event may rarely occur (7).
In the areas of proliferation of the prickle cells are numerous
vacuolated cells, twice or three times as large as the normal cells,
with small, irregular, deeply staining nuclei. They resemble the
clear cells of Paget's disease of the nipple, except that intercellular
bridges are present. The vacuolation is not caused by ordinary
edema but represents, like isolated keratinization, a phenomenon
of dyskeratosis. Another feature is the presence of giant cells
induced by clumping of epithelial cells or by amitosis. A dense
infiltrate of lymphocytes and sometimes of plasma cells usually
occurs in the subjacent cutis (fig. 3a and b).
Arsenical epitheliomas occurring on the trunk independently of
keratosis are multiple lesions of varying size, with seborrhea-like
or verrucous crusts, the removal of which uncovers a wide, rolled,
pearly, indurated border (fig. 4). The histopathologic picture is
identical with that of epithelioma arising from arsenical keratosis,
with the exception that basal cell epithelioma occasionally appears
in arsenical epithelioma on the trunk. Hyperkeratotic and para-
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Fm. 3e. Arsenical epithelioma of trunk simulating Bowen's disease. Histo-
logically early squamous cell epithelioma, grade 3, with marked vacuolation of
some of the cells and dense infiltrate in the upper cutis; b, arsenical keratosis,
squamous cell epithelioma, grade 3, which has penetrated deep in the cutis but
retains all the phenomena of individual cell keratinization with abnormal mitosis,
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keratotic scales often are heaped over the lesion; rete ridges which
are irregularly acanthotic, appear elongated, broadened and
bulbous. Proliferation of prickle cells takes place in a disorderly
crowded arrangement, with resulting variability in size and
staining plus the aforementioned features of individual-cell kera-
tinization, mitotic and amitotic cell division and vacuolation
(fig. 3b).
Fin. 4. Large arsenical epithelioma from back of patient who had multiple
lesions; histologically squamous cell epithelioma, grade 2. Note elevation and
wide, rolled border of the lesion and eczematoid and crusted epitheliomatous
plaques adjacent to the large lesion.
Recently Goeckerman and Wilhelm (8) published a report on
arsenical cancer of mucous membrane, which they suggested
might be more common than is generally considered, if the lesion
develops in the absence of classic cutaneous epithelioma. We
S
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have had under observation a patient who had two arsenical
carcinomas of mucons membranes (9). This case was reported
(as case 2) in the earlier study by the senior anthor in 1935. An
abstract of the complete history follows:
Case 4. A farmer, aged forty-two years, was first seen at the clinic in 1927.
A tumor of the left sole arose from an arsenical keratosis. The lesion proved to
be squamous cell epithelioma, grade 3. Treatment consisted in excision of the
lesion, followed by application of radium to the enlarged inguinal nodes.
During the following seven years numerous superficial epitheliomas of the
arsenical type developed on the trunk. In 1934 these were found to be squamous
cell epitheliomas of grade 1 and grade 2, in which crystals of arsenic were demon-
strated by Osborne's stain. Also present was one superficial epithelioma, which
histologically was a basal cell cancer. At the same examination the patient was
found to have an intra-urethral epithelioma, grade 3, of the arsenical type. Par-
tial amputation of the penis was performed.
In 1938 the patient returned. Bronchoscopic examination disclosed a tumor
of the bronchus. Microscopically this was found to be epithelioma, grade 4,
with vacuolation of cells and malignant dyskeratosis characteristic of the arsenical
type of epithelioma. The patient died in February, 1940 of extensive metastasis.
In addition to the feature of arsenical carcinomas arising on
mucons membranes, this case also illustrates the benign prognosis
with regard to cutaneous tumors observed during a total period
of thirteen years, as well as with regard to the intra-urethral
tumor which showed no evidence of recurrence up to the patient's
death six years later.
DIFFERENTIAL DIAGNOSIS AND PROGNOSIS
Bowen's disease (3) is characterized clinically by solitary lesions
with arciform configuration or by multiple lenticnlar plaques
simulating the uodulo-ulcerative syphiloderm. Undoubtedly this
picture may be simulated by the arsenical epithelioma. The
histologic structure which is not unique but is found also in other
precancerous dermatoses is that of squamous cell epithelioma in
situ, with features of abnormal keratinization of individual cells,
clumping of cells to form epithelial giant cells, and amitotic cell
division producing giant epithelial cells; all these are phenomena
of so-called malignant dyskeratosis. Vacuolation of cells also
may be present, but usually this feature is not so prominent as
it is in arsenical epithelioma.
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Superficial epitheliomatosis (2) includes grossly two types of
lesions, the "dry" form, usually basal cell epithelioma, and the
"moist" or eczematoid form, usually basal squamous or squamous
cell epithelioma (fig. 5). The fine, threadlike, rolled pearly border
and the relative lack of induration characterize the individual
FIG. 5. Lesions of superficial epitheliomatosis of seven years' duration from a
man, aged sixty-one years. The upper moist eczematoid lesion histologically
is a basal squamous cell epithelioma. The other dry lesions are typical for
superficial epitheliomatosis. In the large dry lesion a fine threadlike pearly
border can be discerned.
patches, among which the basal cell form is the more common.
Histologic Bowen-like changes occur only exceptionally in super-
ficial epitheliomatosis (10); the case published by Voss (11) prob-
ably represents such. an occurrence rather than the presence of
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the arsenical epithelioma makes for ready distinction from the
patch of superficial epitheliomatosis. Contrary to Anderson's
(12) observations, a history of ingestion of arsenic is rarely ob-
tained, nor is arsenic usually found within the tissues of super-
ficial epitheliomatosis.
For the purpose of prognosis it is important to distinguish
arsenical epitheliomas from the lesions of superficial epithelio-
matosis and Bowen's disease. The work of one of us (2) (II. M.)
has indicated the relatively benign character of superficial epi-
thelioma. It also has been shown that, although penetrating
epithelioma will develop in approximately 20 per cent of cases
of Bowen's disease, the lesion may be present for years and even
decades without increase in size. The degree of malignancy of
epitheliomas attributable to arsenic as determined histologically,
is usually of grade 2 or 3, but the clinical course is generally that
of squamous cell epithelioma of grade 1 or 2. They are therefore
somewhat of an exception to the rule of parallelism between the
histologic grading (Broders) and the clinical course of malignancy.
This aspect of the arsenical epithelioma may require further study.
Arsenical epitheliomas, although not usually of a high degree of
malignancy in their behavior, more often lead to invasive growth
and metastasis than the majority of cases of Bowen's disease.
TREATMENT
Radical measures, consisting either of surgical removal or de-
struction by cautery, constitute the most satisfactory treatment
for the arsenical epithelioma. Experience has indicated repeat-
edly the inadequacy of radiotherapy in these cases, recurrences
often following application of large doses of radium or roentgen
rays to the lesions. Periodic re-examinations of the skin for the
detection and treatment of early new lesions is an essential pro-
cedure in every case.
COMMENT
One of us (1) (H. M.) previously expressed the opinion that in
cases of epithelioma specifically provoked by arsenic, the arsenic
can be demonstrated in the tissues by chemical or by histochemical
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procedures. Further experience has indicated to us that, because
of the small quantities of arsenic which are often present in the
specimen, the quantitative microchemical determination some-
times may yield negative results. The minute quantities of
arsenic reported in some specimens probably signify that in these
cases the amounts of arsenic are just on the threshold of analytic
detection.* So far we have not encountered any sections of
arsenical epithelioma in which treatment by Osborne's method
has not succeeded in demonstrating the characteristic crystals
in the tissue, regardless of the results of chemical analysis. The
same cannot be said for all cases of superficial epitheliomatosis.
Indeed, in a series of cases of superficial epitheliomas which we
observed, no arsenic whatever was detected in the tumors in the
majority of cases. This fact might be interpreted as providing
some argument against the role of arsenic in the pathogenesis of
superficial epitheliomatosis. For the proper evaluation of the
crystals in the tissues, we cannot recommend too emphatically
the necessity for applying the diagnostic criteria described by
Osborne (6, 13).
In a "control" series of tissues studied we have established a
high correlation between the results of the histochemical and
chemical technics. Although we have yet to encounter tissue
in which, with a positive chemical test, arsenic cannot be demon-
strated histologically, the converse does not hold, for often the
Osborne test gives positive results when the results of chemical
analysis are negative, just as occasionally happens in arsenical
epithelioma.
In the few cases in which we found arsenic in lesions of super-
* We feel, contrary to the findings of Tannenholz and Muir (Tannenholz,
Harold, and Muir, Kathleen B.: Methods for microchemical demonstration of
arsenic in tissues, Arch. Path., 15: 789, 1933), that Osborne's technic is very
sensitive for demonstrating traces of arsenic in amounts too small to yield positive
results on quantitative chemical tests. The qualification must be re-emphasized,
however, that the identification of crystals of arsenic trisulfide is not a simple
matter, for the Osborne technic is sometimes capricious, and artefacts may
mislead the inexperienced observer. Considerable practice is required to dis-
tinguish with facility the greenish yellow, haloed, refractile particles of arsenic
trisulfide from granules of pigment and other forms of extraneous depositions
in the skin.
378 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
ficial epitheliomatosis, the quantity of the arsenic was practically
always less than in the adjacent normal skin, whereas in the
arsenical epitheliomas the quantity of the arsenic is more than
in the adjacent normal skin. Since arsenic may be demonstrated
frequently in tissues even in the absence of a satisfactory history
of exposure to the agent, it is not surprising to find it occasionally
in some lesions of superficial epitheliomatosis; nor does this finding
weaken our conclusion with regard to the distribution of arsenic
in the arsenical epithelioma. Also the hypothesis of Fischer-
Wasels (14) must be recalled, that arsenic acts as an activator of
latent cancerous foci in the skin. Invoking this concept, one of
us (3) (II. M.) has attempted to explain why both arsenical and
superficial epitheliomas at times occur together in certain subjects
after exposure to, or ingestion of, the drug, or why areas of basal
cell epithelioma appear adjacent to areas of squamous cell
epithelioma.
As reports in the new and older literature attest, the opportuni-
ties for exposure to arsenic are numerous. Boos and Werby (15)
and Cannon (16) recently enumerated possible food sources for
the ingestion of arsenic, and Barksdale (17) has implicated tobacco
as a cause for arsenical reactions in the sensitized skin. Un-
doubtedly the medicinal administration of arsenic accounts for
the provocation of epithelioma in the majority of cases, but in
cases in which no adequate history is provided to indicate the
source, the ingestion or inhalation of minute quantities of arsenic
through food, tobacco or industrial exposure may be sufficient
to precipitate characteristic precancerous and cancerous changes
in the skin of some predisposed persons.
SUMMARY AND CONCLUSIONS
The concept that arsenical epithelioma is associated with a
local concentration of arsenic in the tissue is confirmed by exami-
nation of additional material. In contrast with this finding, the
lesions of superficial epitheliomatosis usually show no evidence
of accumulation or storage of arsenic. We have indicated the
value of the histochemical method for demonstrating arsenic in
the tissues to supplement the procedure of direct chemical analysis.
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Clinical and histopathologic distinctions of arsenical epithe-
lioma from superficial epitheliomatosis and Bowen's disease are
drawn, to emphasize the practicality of regarding each disease
properly as a separate entity. Epithelioma provoked by arsenic
usually is relatively benign, and case histories are cited which
illustrate this point.
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DISCUSSION
Da. S. W. BECKER, Chicago: The authors are to be congratulated on having
such a large number of arsenical carcinomas to study. In our Clinic we have had
very few. One point should be considered in some detail. The conclusions
presented were based on the apparent finding of arsenic by the hydrogen sulfide
method. This method was introduced many years ago, and has been used by
several workers, notably Osborne, in this country.
As one reads the very early work, the method was not properly controlled.
Some years ago, in 1933, in our Clinic, we undertook some arsenical studies and
used this method. To our surprise we found the same crystals in the controls as
in the abnormal specimens. For two years we tried to find out what was wrong
with the method, and to prove that this was arsenic. We were not able to do so.
At the same time in Vienna, another group tried to prove this, and two papers
(Tannenholz, H., and Muir, K.B.: Methods for Microchemical Demonstration of
Arsenci in Tissues, Arch. Dermat. & Syph., 15: 789 (June) 1933. Oppenheim, M.,
und Fantl, P.: Ueber Hauterkrankungen, verursacht durth arsenhaltige Wand-
farben II. Versuche zum histologischen Nachweis von Arsenverbindungen in
der Haut, Archiv. f. Dermat. u. Syph., 170: 488, 1934.) appeared with the same
conclusions. Dr. Oppenheim, working with Dr. Fanti, made a more extensive
study than ours, and I think it appropriate to hear from Dr. Oppenheim.
DR. MAURICE OPPENREIM, Chicago: I wish to thank Dr. Becker for mentioning
my work in collaboration with Dr. Fantl. We published 3 papers in the Archives
of Dermatology, Biology and Physical Chemistry on this subject. Dr. Mont-
gomery has shown us a great number of cancers caused by arsenicals, and we can
confirm this, especially in occupational cases, in certain trades, as feather dyers,
animal stuffers, and all people dealing with arsenical compounds, and those stain-
ing wall papers, using wall dyes, living in rooms covered with arsenicals contained
in wall dyes and wall papers. Sometimes we see the originating warts, and later
the cancers.
It was very peculiar for us to find that if we used arsenic in therapeutic doses
given over long periods continually for months and years, in cases of neoars-
phenamine used in syphilis also, we never saw this. We made experiments and
found that the effect of arsenic on the skin is definite. Some compounds of arsenic
are accumulated in the hair, nails and scales, in the horny part. In other cases it
affects the pigment in epidermis and cutia, which has a definite affinity for arsenic.
As you know, arsenical melanoses are a very common observation. We found
out that the various arsenic compounds have varying degrees of affinity for the
tissues of the skin. In our investigations we found all the methods used to prove
the presence of arsenic in the skin by microchemical methods are to be doubted.
Fanti and I carried out experiments in vitro in animals and man, and we could not
definitely find the yellow transparent crystals—nothing was found in the connec-
tive tissue. Therefore we are doubtful if any of these cases quoted by Dr. Mont-
gomery as having all these findings are really arsenic. The same held true for the
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microchemical histological proof of mercury in the skin which was studied by
Justus in Hungary. So we are very critical concerning the proof of arsenicals by
microchemical methods.
It must be a certain kind of arsenic, which causes cancer. We see the same in
tar cancer. Not all tars cause cancer of the skin. And in the same way, perhaps,
a certain type of arsenic is causing arsenical cancers, another, rather melanosis, a
third one more hyperkeratosis etc. I could not find in this country, skin disorders
caused by wall dyes and wall papers containing arsenic as it is the case in Austria,
where the occasion of arsenic intoxication is much greater, and consequently more
cases of chronic arsenic intoxication are observed, but we could not ascertain in
which way or form arsenic was absorbed from wall dye and wall paper. It would
be very interesting if we could find out.
I am sorry that our investigations were interrupted by the political conditions.
I present only one slide showing arsenical cancer of the heel of a feather dyer with
arsenical dyes; this was a prickle cell cancer, which is usually observed in cases of
chronic arsenic intoxication. The hyperkeratosis was not as intense as we are
accustomed to see it.
Da. NELSON PAUL ANDERSON, Los Angeles: I think that the only fact that Dr.
Montgomery and I agree on in this matter is that the kerotoses appearing on the
palms and soles are due to arsenic. From then on we rapidly diverge. My im-
pression, since the first work done in 1932, is that the great majority of cases of
so-called superficial epitheliomas of the trunk are due to arsenic. I have had no
reason to change that opinion.
In the past 9 years I have observed at least 39—40 cases of superficial epithelio-
mae in which arsenical keratoses were present on the palms and soles. Whether
one accepts this as evidence of arsenical origin makes very little difference. It is
very peculiar, however, that this circumstance happens. I think Dr. Goecker-
man performed a great service last year in calling attention to the fact that
arsenic should be looked upon as a causative factor in some mucous membrane
epitheliomas. He presented a case of papillomas of the bladder and multiple
epitheliomas of the body and arsenical keratoses of the palms and soles, but on
looking back into the literature you find that this is not so uncommon.
At the time of Dr. Goeckerman's presentation, Dr. Everett C. Fox of Dallas
mentioned Dr. Fraser's case, which we both treated. This patient was treated
only once a month, because he was being treated for papiflomas by a urologist.
Later, Dr. Goldman and Dr. Tauber presented a case of superficial epitheliomas
in the British journal of Dermatology in which they described one of their patients
as suffering from papillomatosis of the bladder. I believe that this feature of
arsenic in mucous membrane carcinoma is being neglected.
A third point I would like to make, is one I have only recently run across. I
am sure you are all familiar with the phenomenon of fluoride mottling of the teeth.
I do not wish to malign Texas, but this particular patient I saw came from Texas;
she had arsenical keratosis of the palms and soles, and also fluoride mottling of the
teeth. I do not know whether this has any significance or not. It is just an iso-
lated clinical observation.
I have done no further work on superficial epitheliomas since my original work
in 1932, but at that time I made this observation, which was not published, and
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should have been. Instead of using normal controls with Osborne's micro-
chemical method, I used warts and mucous membrane cancers, including cancers
of the tongue. It was very surprising that positive results were obtained with
cancers of the mucous membranes, and with ordinary verruca vulgares.
Is there really arsenic in such lesions? Do these lesions have a sort of arseno-
tropism, e.g., do they pull arsenic in them? I do not know.
Dn. Tuxonoaa CORNBLEET, Chicago: The frequency with which arsenic kera-
toses occur on the palms and soles makes one think that perhaps there must be
some relationship to sweat; indeed sweat contains a great deal of arsenic, and is
one of the major routes for the excretion of arsenic. Of course, hair, nails and
other sites of skin contain arsenic. I wonder if there is not something in oil-
bearing areas which tends to inhibit somewhat the formation of keratoses and
epitheliomas from arsenic. It is an interesting point to follow up.
Arsenic, like halogens, takes a long time to excrete. One can examine a patient
with a disease due to arsenic and find it coming through after 30—50 and more days,
just as do the halogens. In several patients, to whom I have given test doses of
arsenic, and observed the length of time it took to excrete this, I found that those
that have arsenical keratoses take a longer time to excrete a given amount of
arsenic than that taken by my control patients. That is perhaps noteworthy
because it may be that arsenic is retained in the epidermis for protracted periods—
f or too long an interval in some cases, so as to irritate and produce those changes
we find in arsenical keratoses and epitheliomas.
I am also inclined to speculate about Dr. Montgomery's findings in regard to
some epitheliomas having no arsenic at all, and some having more than the control
studies. I should like to ask: 1) are these epitheliomas examined long after ar-
senic had been taken; perhaps all the arsenic had already been excreted, but the
keratoses and epitheliomas continued once initiated; and (2) one should correlate
the amount of epidermal tissue, that is, the number of cells in the epithelioma with
that in the control sites. Of course, where there are more cells present, as in
epitheliomas and keratoses, one would expect to find a greater accumulation of
arsenic.
DR. MORRIS WAISMAN, Chicago: I should like to answer the arguments ques-
tioning the value of the histochemical method for the detection of arsenic. The
majority of lesions of superficial epitheliomatosis in our material showed arsenic
to be absent both by direct chemical analysis and by histochemical examination.
We were impressed by this correlation between the two methods and particularly
by the specificity of the latter procedure, that is, the Osborne technic. Another
observation that cannot be ignored is our finding of characteristic crystals in sec-
tions of every cutaneous lesion in which direct chemical analysis confirmed the
presence of arsenic. Moreover, in the arsenical epitheliomas, where chemical
examination shows the arsenic to be concentrated in the tumor as compared with
the adjacent normal epidermis, we found by Osborne's method a parallel concen-
tration of crystals within the epitheliorna, with fewer crystals or none in the neigh-
boring epidermis. These results make a strong case for the dependability of the
histochemical findings.
It should be emphasized again that the interpretation of refractile granules
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under the microscope is a difficult task, and that strict criteria must be employed
for distinguishing crystals of arsenic trisulfide from various adventitious particles
which may be visible in a section of tissue. Of course the quantitative chemical
method is not liable to this same subjective handicaps. In our study we found by
the quantitative (Gutzeit) method generally more arsenic within the arsenical
epithelioma than in the adjacent skin, and we have simply reported the fact, which
confirms the conclusion reached by Dr. Montgomery in 1935. We obviously did
not undertake to reinvestigate Osborne's work, but we are satisfied from the com-
parison with our quantitative data that Osborne's method is reliable for the de-
tection of small amounts of arsenic in the tissues.
DR. HAMILTON MONTGOMERY, Rocheater, Minn.: Arsenic is definitely a car-
cinogenic substance and pentavalent arsenic has an affinity for the epidermis.
Ebert showed that local application of arsphenamine to the skin could result in
Bowen-like changes. Rarely have arsenical keratoses appeared following use of
trivalent arsenicals including arsphenamine. Some physicians hesitate to use
arsenicals in the treatment of syphilitic. leukoplakia because of the danger of
precipitating true malignant change. Arsenic may be demonstrable in the tissue
thirty years or more after the patient has stopped taking arsenic. We believe
Osborne's modification of the Brunauer method for determining arsenic in tissue
to be a reliable one if done on fresh tissue and freshly fixed formalin. The method
had been controlled and checked against quantitative chemical analysis by Oster-
berg's modification of Guzeit's method. More arsenic can usually be demon-
strated in areas of arsenical epithelioma or arsenical keratosis than in adjacent
normal skin. In answer to Doctor Cornbleet, the amount of arsenic demonstrated
is many times in excess of the amount that would be regarded as the upper limits
of normal arsenic content of the skin, even of persons with a known exposure to
arsenic in various forms.
The majority of cases of superficial epitheliomatosis give no history of inges-
tion of arsenic and none can be demonstrated by either method of chemical analy-
sis. In about 15 per cent of our cases, both lesions of superficial epitheliomatosis
and arsenical epithelioma were present in the same individual. Discrepancies be-
tween our figures and those of Doctor Anderson may be on the basis that in the
part of the country from which his cases come the patients may be exposed to
arsenic. Arsenic as a carcinogenic substance can stimulate latent or dormant
foci of epithelioma and thus explain the combination of the two types of super-
ficial epitheliomas in the same individual.
